416 related articles for article (PubMed ID: 33169334)
1. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
[TBL] [Abstract][Full Text] [Related]
2. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG
PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729
[TBL] [Abstract][Full Text] [Related]
3. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
6. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
Begum S; Gillison ML; Nicol TL; Westra WH
Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
[TBL] [Abstract][Full Text] [Related]
7. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
[TBL] [Abstract][Full Text] [Related]
8. Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 System.
Kerr DA; Sweeney B; Arpin RN; Ring M; Pitman MB; Wilbur DC; Faquin WC
Arch Pathol Lab Med; 2016 Aug; 140(8):844-8. PubMed ID: 27031775
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
[TBL] [Abstract][Full Text] [Related]
10. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
11. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
12. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
[TBL] [Abstract][Full Text] [Related]
13. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
14. Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.
Biesaga B; Mucha-Małecka A; Janecka-Widła A; Kołodziej-Rzepa M; Szostek S; Słonina D; Kowalczyk A; Halaszka K; Przewoźnik M
J Cancer Res Clin Oncol; 2018 Jan; 144(1):63-73. PubMed ID: 29043437
[TBL] [Abstract][Full Text] [Related]
15. Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.
Ursu RG; Danciu M; Spiridon IA; Ridder R; Rehm S; Maffini F; McKay-Chopin S; Carreira C; Lucas E; Costan VV; Popescu E; Cobzeanu B; Ghetu N; Iancu LS; Tommasino M; Pawlita M; Holzinger D; Gheit T
PLoS One; 2018; 13(6):e0199663. PubMed ID: 29940024
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.
Guo M; Khanna A; Wang J; Williams MD; Kalhor N; Gong Y; Xu L; Sturgis EM; Staerkel G
Arch Pathol Lab Med; 2019 Mar; 143(3):356-361. PubMed ID: 30221979
[TBL] [Abstract][Full Text] [Related]
17. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
18. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
